Recently_1777294237270_124456903.png&w=64&q=75)
Source:
الوطن
Eight years battling cancer
Here is the requested summary: A retired British man, Ken Theobald, aged 76, was diagnosed in 2018 with a high-grade multiple myeloma. Doctors predicted he would pass away within two years. However, he participated in a clinical trial combining an intensive regimen of five medications and stem cell transplantation, which allowed him to live for another 8 years. He now spends his life traveling with his wife and visiting his grandchildren. The study showed that 70% of patients who received the tailored therapy remained alive after 6 years, compared to 40% in standard treatment. Additionally, disease progression was halted in 54% of participants, versus 18% in the other group. These results demonstrate the effectiveness of targeted treatment based on the genetic characteristics of the disease in improving survival rates.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)